US Patent 9546204 Recombinant FSH including alpha 2,3- and alpha 2,6-sialylation
All edits
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+61 characters)
Article
Patent abstract
Preparations including recombinant FSH (rFSH).
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09546204 Recombinant FSH including alpha 2,3- and alpha 2,6-sialylation US Patent 9546204 Recombinant FSH including alpha 2,3- and alpha 2,6-sialylation
Infobox
Patent Number
0954620400
Patent Number
954620400
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
095462040
Date of Patent
January 17, 2017
0Patent Application Number
145418520
Date Filed
November 14, 2014
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
095462040
Date of Patent
January 17, 2017
0Patent Application Number
145418520
Date Filed
November 14, 2014
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 09546204 Recombinant FSH including alpha 2,3- and alpha 2,6-sialylation
Infobox
Is a
Patent jurisdiction
Patent number
09546204
Date of patent
January 17, 2017
Patent application number
14541852
Date Filed
November 14, 2014
Patent primary examiner
Find more entities like US Patent 9546204 Recombinant FSH including alpha 2,3- and alpha 2,6-sialylation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
